SEARCH CONTACT US

ACCESSIBILITY

24/7

Headlines

Who pays when an AI agent tries again?

Brandlight helps enterprise marketers manage how AI recommends their brand

BlueGreen Water Technologies turns algae blooms into large-scale carbon removal

Taboola to acquire Dianomi for up to £27 million as it pushes deeper into finance advertising

Buzz

Most popular

Daily

Weekly

1

Serbia opens Israeli drone factory as defense ties with Elbit deepen

2

The man who helped build Palo Alto’s Cortex is leaving the company

3

“Our next milestone will be a billion-dollar valuation”: MIND triples valuation to $300 million with $72 million Series B

4

How an Israeli engineer went from Rafael to iPhone Portrait Mode and a $300 million OpenAI exit

5

Sayeret Matkal veterans raise $22 million to teach the world English with AI

Antibody

2 stories about Antibody

בניין חברת טבע כפר סבא

Teva moves closer to a drug for celiac disease with positive Phase 2 results

02.09.26|Sophie Shulman

The company's TEV-408 antibody met its primary endpoint in a 50-patient trial and reduced intestinal damage, inflammation and gastrointestinal symptoms. Teva is also advancing the treatment for vitiligo, potentially expanding the commercial opportunity for the same drug.

המכון הביולוגי נס ציונה

Bennett Hails Breakthrough in Discovery of Covid-19 Antibody as Israel Eases Quarantine Regulations

05.05.20|CTech, Ynet News

The government cancels local travel restrictions and sets out a schedule for the full return to school